86 related articles for article (PubMed ID: 18437146)
1. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
Xi GL; Cheng JW; Lu GC
Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
[TBL] [Abstract][Full Text] [Related]
2. TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.
Morris DR; Cunningham MA; Ahimastos AA; Kingwell BA; Pappas E; Bourke M; Reid CM; Stijnen T; Dalman RL; Aalami OO; Lindeman JH; Norman PE; Walker PJ; Fitridge R; Bourke B; Dear AE; Pinchbeck J; Jaeggi R; Golledge J
Trials; 2015 Jun; 16():274. PubMed ID: 26081587
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study.
Bolotova O; Yoo J; Chaudhri I; Marcos LA; Sahib H; Koraishy FM; Skopicki H; Ahmad S; Mallipattu SK
PLoS One; 2020; 15(12):e0244708. PubMed ID: 33378401
[TBL] [Abstract][Full Text] [Related]
4. Three-Year Cardiovascular Outcomes of Telmisartan in Patients With Hypertension: An Electronic Health Record-Based Cohort Study.
Yum Y; Kim JH; Joo HJ; Kim YH; Kim EJ
Am J Hypertens; 2024 May; 37(6):429-437. PubMed ID: 38285627
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: a network meta-analysis.
Zhang Z; Yang H; Guo H
Int J Clin Pharm; 2024 Jun; ():. PubMed ID: 38861046
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.
Vitale C; Mercuro G; Castiglioni C; Cornoldi A; Tulli A; Fini M; Volterrani M; Rosano GM
Cardiovasc Diabetol; 2005 May; 4():6. PubMed ID: 15892894
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin receptor blockers in patients with hypertrophic cardiomyopathy: A comparison of VANISH and INHERIT randomized trials.
Severinsen T; Thune JJ; Gudmundsdottir HL; Vissing CR; Iversen K; Ho CY; Bundgaard H; Axelsson Raja A
Am Heart J; 2023 Dec; 266():198-200. PubMed ID: 37980092
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
[TBL] [Abstract][Full Text] [Related]
9. Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients.
Hasegawa H; Takano H; Narumi H; Ohtsuka M; Mizuguchi T; Namiki T; Kobayashi Y; Komuro I
Hypertens Res; 2011 Nov; 34(11):1179-84. PubMed ID: 21796128
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.
Lee CJ; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
J Hypertens; 2017 May; 35 Suppl 1():S33-S40. PubMed ID: 28129248
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan and cardioprotection.
Akhrass PR; McFarlane SI
Vasc Health Risk Manag; 2011; 7():677-83. PubMed ID: 22140319
[TBL] [Abstract][Full Text] [Related]
12. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A
N Engl J Med; 2014 Oct; 371(17):1609-18. PubMed ID: 25337750
[TBL] [Abstract][Full Text] [Related]
13. Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trial.
Huber M; Treutler T; Martus P; Kurzidim A; Kreutz R; Beige J
PLoS One; 2013; 8(11):e79322. PubMed ID: 24260194
[TBL] [Abstract][Full Text] [Related]
14. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM; Bhatt DL; Braunwald E; Steg PG; Davidson J; Hirshberg B; Ohman P; Frederich R; Wiviott SD; Hoffman EB; Cavender MA; Udell JA; Desai NR; Mosenzon O; McGuire DK; Ray KK; Leiter LA; Raz I;
N Engl J Med; 2013 Oct; 369(14):1317-26. PubMed ID: 23992601
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension.
Zheng Z; Lin S; Shi H
J Clin Hypertens (Greenwich); 2010 Jun; 12(6):414-21. PubMed ID: 20591086
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
Hypertens Res; 2013 Nov; 36(11):959-66. PubMed ID: 23945962
[TBL] [Abstract][Full Text] [Related]
17. Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
Nixon RM; Müller E; Lowy A; Falvey H
Int J Clin Pract; 2009 May; 63(5):766-75. PubMed ID: 19392925
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study.
Kalikar M; Nivangune KS; Dakhale GN; Bajait CS; Sontakke SD; Motghare VM; Budania R
J Pharmacol Pharmacother; 2017; 8(3):106-111. PubMed ID: 29081617
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: A meta-analysis.
Kumari K; Toppo MS; Majhi L; Kumar A
J Family Med Prim Care; 2022 Oct; 11(10):6227-6235. PubMed ID: 36618237
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan - Systematic Review and Network Meta-Analysis.
Nakajima T; Oh A; Saita S; Yoshida T; Ohishi M; Nishigaki N
Circ Rep; 2020 Sep; 2(10):576-586. PubMed ID: 33693183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
